I was a very early investor in both healthcare and biotech, particularly focusing on early-stage companies looking to utilise the latest advancements in technology to make much-needed breakthroughs in their fields. In addition, they are examples of females who were confident and not shy to take on the challenge to https://nicole-junkermann-instagr62616.rimmablog.com/13925213/la-mejor-parte-de-nicole-junkermann-linkedin